Updated:
ICH Asset Management
ICH Asset Management — the Cha family office — stewards pharmaceutical-sale wealth through a concentrated portfolio of prime London commercial real estate.
ICH Asset Management
ICH Asset Management was formed to steward the wealth generated by the Cha family's exit from Ildong Pharmaceutical Co., a major South Korean drug distributor. Unlike family offices that diversify broadly across asset classes, the firm's mandate narrowed early around direct property investments in Central London, where it has built a discreet but substantial portfolio of office and retail assets. The strategy centers on acquiring freehold interests in well-located commercial buildings, holding them for long-duration income, and selectively recycling capital when London pricing cycles peak. ICH's known positions are concentrated in the West End and City submarkets — trophy-adjacent assets that appeal to institutional tenants rather than speculative development. The family has historically avoided leverage-heavy structures, preferring all-cash or low-loan-to-value acquisitions that protect against currency volatility between the won and sterling. A defining transaction was the £340 million acquisition of the Goldman Sachs London headquarters building at 120 Fleet Street, executed in partnership with other Korean investors in 2018. The office runs with a lean team, likely fewer than a dozen professionals, reflecting a governance model where investment decisions are centralized with the family patriarch. ICH does not raise external capital, operates no parallel fund vehicles, and maintains no public-facing presence. Its professional network is concentrated among London commercial agents — particularly those handling off-market West End listings — and the tight circle of Korean family offices that co-invest alongside each other in European property. In November 2022, ICH sold 40 Chancery Lane to a Singaporean family office for approximately £120 million, having owned the asset since 2013 — a hold period indicative of its patient-capital approach. The firm's structural distinction lies in its single-jurisdiction conviction. While most Asian family offices diversify at least partially across geographies or asset classes, ICH has effectively operated as a pure-play London real estate holding company for nearly two decades, absorbing Brexit uncertainty, pandemic disruption, and sterling depreciation without shifting the mandate. That concentration is paired with an unusual internal decision velocity — principals can close transactions without investment committee layers — making ICH a preferred counterparty for vendors seeking speed and certainty. The succession plan is not publicly articulated, but the absence of next-generation principals in deal-level roles raises the question of whether the portfolio will eventually be capitalized into a more institutional structure.
General information
Firm type
Single Family Office
Year founded
—
AUM
Undisclosed
Location
Region
—
Country
—
City
—
Corporate office
—
Sector focus
Frequently asked questions
Who runs investment decisions at ICH Asset Management?
Investment authority is understood to rest with the Cha family patriarch, consistent with the centralized governance model typical of first-generation Korean family offices. The firm does not list external investment committee members or non-family CIOs. Deal execution runs through a small London-based team and long-tenured advisory relationships with UK commercial property agents.
How does ICH Asset Management source its real estate deals?
Sourcing relies on deep relationships with London's major commercial brokerage firms — particularly those with active off-market desks in the West End and City submarkets. ICH's reputation for all-cash closings and absence of financing contingencies gives it an advantage in competitive bidding situations. The firm also co-invests selectively with other Korean family offices, creating a parallel origination channel through shared deal flow.
Is ICH structured as a single-family office or does it manage outside capital?
ICH operates strictly as a single-family office serving the Cha family. It does not accept external capital, does not manage third-party funds, and has no publicly registered investment advisory entity. The investment activity is funded entirely by family equity, predominantly from the liquidation of the family's pharmaceutical holdings.
Where does the underlying wealth come from?
The Cha family's wealth originates from Ildong Pharmaceutical Co., one of South Korea's largest pharmaceutical wholesale and distribution companies. The family held a controlling stake for decades before exiting, converting that illiquid operating-company equity into liquid capital that became the corpus of ICH Asset Management's real estate portfolio.
What is ICH Asset Management's known posture on co-investments alongside external GPs?
ICH co-invests occasionally alongside other Korean family offices in larger London property transactions, as seen in the £340 million acquisition of 120 Fleet Street in 2018. The firm does not commit to blind-pool funds or external GP structures. Its co-investment activity is limited to direct asset-level partnerships where the underlying property is already identified.
Does ICH Asset Management invest in asset classes beyond London commercial real estate?
Public record shows no evidence of diversification beyond London commercial property. The firm has not disclosed positions in equities, fixed income, venture capital, private equity funds, or real estate outside the UK. The mandate appears intentionally narrow — a single-asset-class, single-geography conviction bet sustained over multiple market cycles.
What is the succession plan for ICH Asset Management?
No public succession plan has been articulated. Next-generation Cha family members are not visible in deal documentation or UK corporate filings tied to ICH entities. This opacity is consistent with Korean family-office norms, where governance transitions are typically private and may not occur until the founding generation exits active management. The portfolio's eventual institutionalization — or liquidation — remains an open question for counterparties with long-duration exposure to ICH-held assets.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: